Your browser doesn't support javascript.
loading
GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.
Aslan, Nevin Alayvaz; Avci, Esin; Senol, Hande; Güler, Nil.
Afiliación
  • Aslan NA; Pamukkale University School of Medicine, Denizli, Turkey.
  • Avci E; Pamukkale University School of Medicine, Denizli, Turkey.
  • Senol H; Pamukkale University School of Medicine, Denizli, Turkey.
  • Güler N; Pamukkale University School of Medicine, Denizli, Turkey.
J Investig Med ; 72(4): 341-348, 2024 04.
Article en En | MEDLINE | ID: mdl-38415361
ABSTRACT
Acute myeloid leukemia (AML) is a hematologic malignancy characterized by the proliferation of CD34 positive self-renewing malignant hematopoietic stem cells. Previous studies have shown that the transforming growth factor beta (TGFß) pathway plays a role in AML pathogenesis, especially by affecting the microenvironment. Growth differentiation factor 11 (GDF11) is a member of the TGFß superfamily, involved in embryological development and known as rejuvenating factor. In this study, our aim was to determine the serum GDF11 level in patients with AML, to compare it with the control group, to determine its relationship with follistatin, vimentin, and E-cadherin levels, and to determine whether GDF11 influences AML prognosis. Serum GDF11, vimentin, follistatin, and E-cadherin levels of newly diagnosed or relapsed/refractory AML patients and age- and gender-matched control group were measured by enzyme-linked immunosorbent assay. Serum GDF11 level was higher in the patient group (263.87 ± 126.54 ng/L) compared to the control group (211.54 ± 61.47 ng/L; p = 0.035). GDF11 level did not change according to age, gender, hemoglobin level, and bone marrow blast rate. No correlation was found between GDF11 level, response rates, and survival status of the patients. A positive correlation was detected between GDF11, E-cadherin, and vimentin levels. As a conclusion, increased serum GDF11 levels in AML patients may be linked to the regeneration ability of leukemic stem cells. There is a need for studies investigating GDF11 expression in myeloblasts.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Folistatina Límite: Humans Idioma: En Revista: J Investig Med Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Folistatina Límite: Humans Idioma: En Revista: J Investig Med Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido